You just read:

Seattle Children's Opens CD22 CAR T-Cell Immunotherapy Trial for Children and Young Adults Whose Leukemia Escapes CD19 CAR T-Cell Therapy

News provided by

Seattle Children's Hospital

Jul 27, 2017, 09:07 ET